Skip to main content
Loading…

Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search.  There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 4 May 2021
  6. Session 6: 13 May 2021 to 8 April 2026
  7. Current session: 14 May 2026 to 21 November 2026
Answer status
Question type

Displaying 5815 questions Show Answers

Order by |

Question reference: S7W-04724

  • Asked by: Alexander Burnett, MSP for Aberdeenshire West, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 03 November 2026
  • Current Status: Answered by Angela Constance on 16 November 2026

To ask the Scottish Government what assessment it has made of the potential for the Insch Hospital site to support integrated community health and social care provision, including diagnostic, rehabilitation, preventative and palliative care services.

Question reference: S7W-04719

  • Asked by: Katy Clark, MSP for West Scotland, Scottish Labour
  • Date lodged: Tuesday, 03 November 2026
  • Current Status: Answered by Angela Constance on 16 November 2026

To ask the Scottish Government for what reason some women with ovarian cancer are offered additional cycles of treatment prior to surgery, what assessment it has made of the impact of this approach on patient outcomes, and how any identified challenges are being addressed.

Question reference: S7W-04718

  • Asked by: Katy Clark, MSP for West Scotland, Scottish Labour
  • Date lodged: Tuesday, 03 November 2026
  • Current Status: Answered by Angela Constance on 16 November 2026

To ask the Scottish Government what action it is taking to ensure that women with ovarian cancer who are assessed as inoperable, or whose surgery is considered not to be possible within services in the West of Scotland, are able to access a second opinion and expertise, particularly when there are differing clinical opinions regarding whether surgery is appropriate.

Question reference: S7W-04738

  • Asked by: Craig Hoy, MSP for Dumfriesshire, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 03 November 2026
  • Current Status: Answered by Jenny Gilruth on 16 November 2026

To ask the Scottish Government how much it has spent on the development and delivery of its bond programme since 1 April 2026, broken down by (a) banking and bookrunner fees, (b) legal advice, (c) credit rating costs and (d) other external advice and costs.

Question reference: S7W-04737

  • Asked by: Craig Hoy, MSP for Dumfriesshire, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 03 November 2026
  • Current Status: Answered by Jenny Gilruth on 16 November 2026

To ask the Scottish Government, regarding the £576 million of savings identified in Annex B, Portfolio Efficiency and Reform Plans, of its Scottish Spending Review 2026, how much had been realised as at 30 September 2026, broken down by portfolio.

Question reference: S7W-04714

  • Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
  • Date lodged: Tuesday, 03 November 2026
  • Current Status: Answered by Angela Constance on 16 November 2026

To ask the Scottish Government what consideration it has given to providing interim access arrangement for Skyclarys for eligible patients living with Friedreich's ataxia in Scotland while assessment of the treatment is ongoing.

Question reference: S7W-04725

  • Asked by: Alexander Burnett, MSP for Aberdeenshire West, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 03 November 2026
  • Current Status: Answered by Angela Constance on 16 November 2026

To ask the Scottish Government what information it holds regarding the progress made by NHS Grampian and Aberdeenshire Health and Social Care Partnership in exploring the creation of a wellbeing hub and additional clinical space within the Insch Hospital site, as agreed by the Integration Joint Board in July 2025.

Question reference: S7W-04723

  • Asked by: Alexander Burnett, MSP for Aberdeenshire West, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 03 November 2026
  • Current Status: Answered by Angela Constance on 16 November 2026

To ask the Scottish Government what discussions it has had with NHS Grampian regarding the future disposal of the Insch Hospital site, and what opportunities exist for the community's proposed alternative model of care to be considered before any disposal is completed.

Question reference: S7W-04715

  • Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
  • Date lodged: Tuesday, 03 November 2026
  • Current Status: Answered by Angela Constance on 16 November 2026

To ask the Scottish Government who is responsible for decisions regarding access to medicines for rare diseases, including Skyclarys for people living with Friedreich's ataxia, and what timescale it anticipates for eligible patients in Scotland to be able to access the treatment.

Question reference: S7W-04704

  • Asked by: Monica Lennon, MSP for Glasgow, Scottish Labour
  • Date lodged: Tuesday, 03 November 2026
  • Current Status: Answered by Jenny Gilruth on 16 November 2026

To ask the Scottish Government, further to the answer to question S7W-04098 by Jenny Gilruth on 29 October 2026, whether it will provide details of the regional summits that are planned for November 2026, including dates, locations, anticipated attendees and arrangements for public participation.